Libraries:

Chiromics has developed proprietary libraries available for purchase. These libraries incorporate state-of-the-art MacMillan group technology to produce accessibly complex medicinal cores.

Screening:

Chiromics can utilize its in-house affinity selection mass spectrometry (ASMS) expertise for screening of client targets against our compound collections for hit identification. Chiromics can provide rapid resysnthesis of putative ligands deriving from in-house ASMS in either racemic or enantiopure form.

Custom synthesis:

In collaboration with clients, Chiromics can perform synthesis of highly customized proprietary libraries. These can be derived from the clients' internal drug discovery efforts or Chiromics' compound screening collections.